11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Spectrum of skin diseases in Maroon villages of the Maroni area, French Guiana

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Due to their genetic characteristics and their high exposure to infectious diseases, Maroons are likely to suffer from a specific spectrum of skin diseases. However, skin disorders have never been explored in this population. We aimed to describe all skin diseases in Maroon villages of the Maroni region in French Guiana.

          Methods

          This retrospective study concerned all patients who consulted in the remote health centers of Apatou, Grand‐Santi, Papaichton, and Maripasoula between October 5, 2017, and June 30, 2020. We included all patients registered with a skin disorder (International Classification of Diseases) in the medical database. We excluded patients whose diagnosis was invalidated after cross‐checking by a dermatologist.

          Results

          A total of 4741 patients presented at least one skin disease, for 6058 different disorders. Nonsexually transmitted infections represented 71.6% of all diagnoses, followed by inflammatory diseases (9.8%) and bites/envenomations (4.6%). The three most frequent conditions were scabies, abscesses, and impetigo. Besides scabies, neglected tropical diseases (NTDs) were still prevalent as we reported 13 cases of leprosy and 63 cutaneous leishmaniasis. Atopic dermatitis (AD) represented only 2.5% of our diagnoses.

          Conclusions

          With the exception of AD, which was less frequent among Maroons, these results are similar to those previously reported in Amerindians. Therefore, a common exposure to rainforest pathogens seems to induce a common spectrum of skin diseases dominated by infections. The high prevalence of NTDs requires specific public health actions.

          Related collections

          Most cited references36

          • Record: found
          • Abstract: found
          • Article: not found

          Melanoma

          Cutaneous melanoma causes 55 500 deaths annually. The incidence and mortality rates of the disease differ widely across the globe depending on access to early detection and primary care. Once melanoma has spread, this type of cancer rapidly becomes life-threatening. For more than 40 years, few treatment options were available, and clinical trials during that time were all unsuccessful. Over the past 10 years, increased biological understanding and access to innovative therapeutic substances have transformed advanced melanoma into a new oncological model for treating solid cancers. Treatments that target B-Raf proto-oncogene serine/threonine-kinase (BRAF)V600 (Val600) mutations using selected BRAF inhibitors combined with mitogen-activated protein kinase inhibitors have significantly improved response and overall survival. Furthermore, advanced cutaneous melanoma has developed into a prototype for testing checkpoint-modulating agents, which has increased hope for long-term tumour containment and a potential cure. These expectations have been sustained by clinical success with targeted agents and antibodies that block programmed cell-death protein 1 in locoregional disease, which induces prolongation of relapse-free, distant-metastasis-free, and overall survival times.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Epidemiological Aspects and World Distribution of HTLV-1 Infection

            The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world, with clusters of high endemicity located often nearby areas where the virus is nearly absent. The main HTLV-1 highly endemic regions are the Southwestern part of Japan, sub-Saharan Africa and South America, the Caribbean area, and foci in Middle East and Australo-Melanesia. The origin of this puzzling geographical or rather ethnic repartition is probably linked to a founder effect in some groups with the persistence of a high viral transmission rate. Despite different socio-economic and cultural environments, the HTLV-1 prevalence increases gradually with age, especially among women in all highly endemic areas. The three modes of HTLV-1 transmission are mother to child, sexual transmission, and transmission with contaminated blood products. Twenty years ago, de Thé and Bomford estimated the total number of HTLV-1 carriers to be 10–20 millions people. At that time, large regions had not been investigated, few population-based studies were available and the assays used for HTLV-1 serology were not enough specific. Despite the fact that there is still a lot of data lacking in large areas of the world and that most of the HTLV-1 studies concern only blood donors, pregnant women, or different selected patients or high-risk groups, we shall try based on the most recent data, to revisit the world distribution and the estimates of the number of HTLV-1 infected persons. Our best estimates range from 5–10 millions HTLV-1 infected individuals. However, these results were based on only approximately 1.5 billion of individuals originating from known HTLV-1 endemic areas with reliable available epidemiological data. Correct estimates in other highly populated regions, such as China, India, the Maghreb, and East Africa, is currently not possible, thus, the current number of HTLV-1 carriers is very probably much higher.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Snakebite envenomation turns again into a neglected tropical disease!

              On June 9th, 2017 WHO categorized snakebite envenomation into the Category A of the Neglected Tropical Diseases. This new situation will allow access to new funding, paving the way for wider and deeper researches. It should also expand the accessibility of antivenoms. Let us hope that it also leads to cooperation among stakeholders, aiming at improving the management of snakebites in developing countries.
                Bookmark

                Author and article information

                Contributors
                blaizot.romain@gmail.com
                Journal
                Int J Dermatol
                Int J Dermatol
                10.1111/(ISSN)1365-4632
                IJD
                International Journal of Dermatology
                John Wiley and Sons Inc. (Hoboken )
                0011-9059
                1365-4632
                29 June 2022
                September 2022
                : 61
                : 9 ( doiID: 10.1111/ijd.v61.9 )
                : 1137-1144
                Affiliations
                [ 1 ] Dermatology Department Centre Hospitalier de Cayenne Cayenne French Guiana
                [ 2 ] Centres Délocalisés de Prévention et de Soins Centre Hospitalier de Cayenne Cayenne French Guiana
                [ 3 ] Tropical Biome and Immunophysiopathology (TBIP), Université de Lille, CNRS, Inserm, Institut Pasteur de Lille, U1019‐UMR9017‐CIIL‐Centre d'Infection et d'Immunité de Lille, Centre Hospitalier de Cayenne Université de Guyane Cayenne French Guiana
                [ 4 ] Laboratory of Parasitology Centre Hospitalier de Cayenne Cayenne French Guiana
                Author notes
                [*] [* ] Correspondence

                Romain Blaizot, md, mph Dermatology Department

                Andrée Rosemon Hospital

                Avenue des Flamboyants

                97300 Cayenne

                French Guiana

                E‐mail: blaizot.romain@ 123456gmail.com

                Author information
                https://orcid.org/0000-0002-7437-2662
                https://orcid.org/0000-0003-3695-6824
                Article
                IJD16324 IJD-2021-3363.R1
                10.1111/ijd.16324
                9543587
                35767188
                885e4d77-4c5f-492e-9753-194d662906f8
                © 2022 The Authors. International Journal of Dermatology published by Wiley Periodicals LLC on behalf of the International Society of Dermatology.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 08 May 2022
                : 29 December 2021
                : 12 June 2022
                Page count
                Figures: 1, Tables: 3, Pages: 1144, Words: 6352
                Categories
                Tropical Medicine Rounds
                Tropical Medicine Rounds
                Custom metadata
                2.0
                September 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.0 mode:remove_FC converted:07.10.2022

                Comments

                Comment on this article